Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 687 · page 1 of 2 of this heading
AASI for Chronic Kidney Disease (CKD)
(Updated 11/25/2015)
AME Assisted Special Issuance (AASI) is a process that provides AMEs the ability to re-
issue an airman medical certificate under the provisions of an Authorization for Special
Issuance of a Medical Certificate (Authorization) to an applicant who has a medical
condition that is disqualifying under Title 14 of the Code of Federal Regulations (14 CFR)
part 67.
An FAA physician provides the initial certification decision and grants the Authorization in
accordance with 14 CFR § 67.401. The Authorization letter is accompanied by
attachments that specify the information that treating physician(s) must provide for the
re-issuance determination. If this is a first-time application for an AASI for the above
disease/condition, and the applicant has all the requisite medical information necessary
for a determination, the AME must defer and submit all of the documentation to the
AMCD or RFS for the initial determination.
AMEs may re-issue an airman medical certificate under the provisions of an
Authorization, if the applicant provides the following:
• An Authorization granted by the FAA;
• A current, detailed status report from the treating physician detailing:
o How long the condition has been stable and asymptomatic;
o If there has been any significant change in eGFR or renal function;
o Any interval development of other complications or abnormal physical
exam findings (such as diabetes, uncontrolled HTN, or clinically significant
proteinuria);
o Most recent lab results including eGFR, creatinine, hemoglobin, hematocrit
and urine albumin or ACR;
o The name and dosage of medication(s) and presence or absence of any
side effects; and
o Statement from the treating physician if there is any evidence of
cardiovascular disease
The AME must defer to the AMCD or Region if:
• The condition is no longer stable (per the treating physician note);
• Dialysis has been started or transplant has occurred;
• The airman is taking a medication that is not acceptable (See Pharmaceuticals –
Antihypertensive) or has aeromedically significant side effects from the
medication;
• Anemia with hemoglobin less than 10 gm/dL or hematocrit less than 30% is
present; or
• The eGFR is 29 or less; (if this occurs, the airman will need to submit additional
testing to show stability [such as inulin clearance testing, creatinine clearance
testing, or a 24-hour urine creatinine result] and the nephrologist’s clinical
interpretation of results, prognosis, and plan for follow up).
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
FAA Guide for Aviation Medical Examiners, Version 10/28/2026. AME Copilot is an independent reference tool, not affiliated with or endorsed by the FAA. The FAA AME Guide is the authoritative source. Types such as “Special issuance” are reading aids; AME Copilot does not make certification decisions.